ARSENIC AND AYURVEDA

被引：24

作者：

TRELEAVEN, J

MELLER, S

FARMER, P

BIRCHALL, D

GOLDMAN, J

PILLER, G

机构：

[1] Royal Marsden Hospital, Sutton, Surrey, London, England

[2] Medical Research Council Toxicology Unit, Carshalton, Surrey, London, England

[3] ICl Laboratories, Runcorne, Cheshire, London, England

[4] Royal Postgraduate Medical School, London, England

[5] Leukaemia Research Fund, London, England

来源：

LEUKEMIA & LYMPHOMA | 1993年 / 10卷 / 4-5期

关键词：

ARSENIC; AYURVEDA; CHRONIC MYELOID LEUKEMIA;

D O I：

10.3109/10428199309148558

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Manufacture of an Ayurvedic arsenic-containing compound is described, which is currently in use in India to control blood counts of patients with haematological malignancies. The efficacy and side effects of this compound are evaluated in the light of the fact that arsenic was recognised to be of use in the control of blood counts from patients with chronic myeloid leukaemia as long as 100 years ago, in the West.

引用

页码：343 / &

共 5 条

[1]

Wyngaarden, Smith, Occupational and environmental medicine, Cecil Textbook of Medicine, pp. 2388-2389, (1990)

[2]

Cutler E.G., Bradford E.H., Action of iron, cod liver oil and arsenic on the globular richness of the blood, Am. J. Med. Sci., 75, pp. 74-79, (1878)

[3]

Forkner C., McNair-Scott T.F., Arsenic as a therapeutic agent in chronic myeloid leukaemia, JAMA, 97, 1, pp. 3-5, (1931)

[4]

Forkner C.E., Clinical aspects of chronic leukaemia, Leukaemia and allied disorders, pp. 126-134, (1938)

[5]

Kandel E.V., LeRoy G.V., Chronic arsenical poisoning during the treatment of chronic myeloid leukaemia, Arch. Int. Med., 60, pp. 846-866, (1937)

← 1 →